{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-100847","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2025-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.580914+00:00","generated_at":"2026-05-17T03:00:33.850276+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Citius Pharmaceuticals raises $6.0M in registered direct offering for LYMPHIR launch","bullets":["Gross proceeds ~$6.0M; net ~$5.5M after placement agent fees and expenses.","Offering: 3,973,510 shares/pre-funded warrants plus 3,973,510 common warrants at $1.51/share.","Common warrants exercisable at $1.40/share, 5-year term; pre-funded warrants at $0.0001/share.","Net proceeds to support commercial launch of LYMPHIR™ and other product candidates.","H.C. Wainwright acted as placement agent; 7.0% cash fee and 278,146 placement agent warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-100847","json":"https://secwatch.observer/filing/0001213900-25-100847.json","markdown":"https://secwatch.observer/filing/0001213900-25-100847.md","text":"https://secwatch.observer/filing/0001213900-25-100847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025100847/0001213900-25-100847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025100847/ea0261909-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:00:33.850276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}